Principia Biopharma Inc. — Form D
Principia Biopharma Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-05. The offering totals $50.0M, of which $50.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-09-05
- Form: D
- Accession: 0001739074-18-000006
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $50.0M
- Investors: 24
- Date of first sale: 2018-08-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-320699
Issuer
- Name: Principia Biopharma Inc.
- CIK: 0001510487
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 400 EAST JAMIE COURT, SUITE 302, SOUTH SAN FRANCISCO, CA, 94080
- Phone: (650) 416-7700
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Srinivas Akkaraju | Director | Palo Alto, CA |
| Martin Babler | Director | South San Francisco, CA |
| Daniel Becker | Director | Cambridge, MA |
| Alan Colowick | Director | Belmont, CA |
| Simeon George | Director | Redwood City, CA |
| Lewis J Shuster | Director | San Diego, CA |
| Peter J Thompson | Director | Menlo Park, CA |
| Nassim J Usman | Director | South San Francisco, CA |
| Martin Babler | Executive Officer | South San Francisco, CA |
| Michael Dybbs | Director | Half Moon Bay, CA |
| Peter Thompson | Director | Chanhassen, MN |
| Peter Thompson, M.D. | Director | La Jolla, CA |
| Peter Thompson, M.D. | Executive Officer | La Jolla, CA |
| Simeon J George, M.D. | Director | San Diego, CA |
| LEWIS J. SHUSTER | Director | SOUTH SAN FRANCISCO, CA |
| NASSIM USMAN | Director | South San Francisco, CA |
| Srini Akkaraju, M.D., Ph.D. | Director | Menlo Park, CA |
| Eliot Charles | Executive Officer | Menlo Park, CA |
| Nassim A Usman, M.D. | Director | Menlo Park, CA |
| Richard A Miller, M.D. | Director | Menlo Park, CA |
Other filings by this issuer (2)
More